Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Not Yet Recruiting

Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL

NCT07012980

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL

NCT06921044

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT

NCT06861348

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Not Yet Recruiting

AZA Combined with R-GemOx for Elderly DLBCL Patients

NCT06778902

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +12 more
Locations: Daping Hospital, Third Military Medical University (Army Medical University) Chongqing, China

View Trial Details

Not Yet Recruiting

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1

NCT06777264

Conditions: Acute Lymphoblastic Leukemia, B Cell ALL, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Dynamic CtDNA-guided Targeted Therapy in DLBCL

NCT06748521

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Microbiome in Blood Cancer and HLH

NCT06734624

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Haemophagocytic Lymphohistiocytosis, +15 more
Locations: University of Nottingham Nottingham, Nottinghamshire, United Kingdom

View Trial Details

Not Yet Recruiting

Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission

NCT06669143

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study

NCT06656234

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor Lymphoma

NCT06652152

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Double Expressor Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details